Expression of MAGE genes in human colorectal carcinoma

Annals of Surgery

Volumn 224, Issue 2, 1996, Pages 183-188

  Mori, Masaki ^a   Inoue, Hiroshi ^a   Mimori, Koshi ^a   Shibuta, Kenji ^a   Baba, Kinya ^a   Nakashima, Hideaki ^a   Haraguchi, Masaru ^a   Tsuji, Koichi ^b   Ueo, Hiroaki ^b   Barnard, Graham F ^c   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA PREFECTURAL HOSPITAL   (Japan)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MAGE ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEMETHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE ISOLATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; AZACITIDINE; BASE SEQUENCE; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 9444249349     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199608000-00011     Document Type: Article

References (25)

1. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254:1643-1647.
2. Traversari C, van der Bruggen P, van den Eynde B, et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992; 35:145-152.
3. Traversari C, van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176:1453-1457.
4. van der Bruggen P, Szikora J-P, Boël P, et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanoma expressing HLA-Cw* 1601. Eur J Immunol 1994; 24:2134-2140.
5. Gaugler B, van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994; 179:921-930.
6. Celis E, Tsai V, Crime C, et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A 1994; 91:2105-2109.
7. van der Bruggen P, Bastin J, Gajewski T, et al. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 1994; 24:3038-3043.
8. Weynants P, Bernard L, Brasseur F, et al. Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 1994; 56:826-829.
9. Brasseur F, Marchand M, Vanwijck R, et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 1992; 52:839-841.
10. Patard J, Brasseur F, Gil-Diez S, et al. Expression of MAGE genes in transitional carcinomas of the urinary bladder. Int J Cancer 1995; 64:60-64.
11. Rimoldi D, Romero P, Carrel S. The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 1993; 54:527-528.
12. Inoue H, Mori M, Li J, et al. Human esophageal carcinomas frequently express the tumor rejection antigens of MAGE genes. Int J Cancer 1995; 63:523-526.
13. Inoue H, Li J, Honda M, et al. MAGE-1 mRNA expression in gastric carcinoma. Int J Cancer 1995; 64:76-77.
14. Inoue H, Mori M, Honda M, et al. Expression of tumor rejection antigen "MAGE" gene in human gastric carcinoma. Gastroenteology 1995; 109:1522-1525.
15. Coulie PG, Weynants P, Lehmann F, et al. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. J Immunother 1993; 14:104-109.
16. Weber J, Salgaller M, Samid D, et al. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-Aza-2′-deoxycytidine. Cancer Res 1994; 54:1766-1771.
17. Chomczynnski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-PhOH-chloroform extraction. Anal Biochem 1987; 162:156-159.
18. De Smet C, Lurquin C, van der Bruggen P, et al. Sequence and expression pattern of the human MAGE-2 gene. Immunogenetics 1994; 39:121-129.
19. Tokunaga H, Nakamura Y, Sakata K, et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987; 47:5616-5619.
20. Brichard V, Van Pel A, Wölfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytotoxic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178:489-495.
21. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor Proc Natl Acad Sci U S A 1994; 91:3515-3519.
22. Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180:35-42.
23. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A 1994; 91:6458-6462.
24. Dong R, Kimura A, Okubo R, et al. HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 1992; 35:165-172.
25. Bird A. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209-213.